Elsevier

Heart Rhythm

Volume 5, Issue 12, December 2008, Pages 1635-1642
Heart Rhythm

Original-clinical
Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter

Presented in part at the Heart Rhythm Society annual meeting, May 2008, San Francisco, California.
https://doi.org/10.1016/j.hrthm.2008.08.037Get rights and content

Background

Pulmonary vein (PV) isolation for ablation of atrial fibrillation (AF) remains a complex and lengthy procedure.

Objective

The purpose of this study was to evaluate the feasibility and safety of a novel multielectrode catheter that delivers duty-cycled bipolar and unipolar radiofrequency (RF) energy.

Methods

Patients eligible for catheter ablation of paroxysmal AF after screening with magnetic resonance imaging and transesophageal echocardiography were included in the study. A decapolar (3-mm electrode, 3-mm spacing, 25-mm diameter), circular, over-the-wire mapping and ablation catheter was deployed in the antrum of each PV. Ablation was performed with 60-second, 60°C applications of duty-cycled bipolar/unipolar RF in a 4:1 ratio simultaneously at all selected electrode pairs until local activity was no longer observed. At 6 months, 7-day Holter monitoring was performed to determine freedom from AF without use of antiarrhythmic drugs.

Results

In 98 patients (mean age 59 ± 9 years), the PV ablation catheter was used for ablation of 369 veins (20 common left antra). All targeted veins (100%) were isolated as confirmed by the absence of potentials in the ostium either by PV ablation catheter or Lasso mapping. Mean number of RF applications was 27 ± 7, total procedural time 84 ± 29 minutes, and fluoroscopy time 18 ± 8 minutes. Follow-up after 6 months without antiarrhythmic drugs showed freedom from AF in 83% of patients. No procedure-related complications were observed.

Conclusion

PV isolation by duty-cycled bipolar/unipolar low-power RF energy through a circular, decapolar catheter can be achieved safely and efficiently, with good efficacy at 6 months.

Introduction

Radiofrequency (RF) catheter ablation has become first-line therapy for patients with drug-refractory atrial fibrillation (AF).1, 2 An early ablation strategy consisted of focal ablation of triggers inside the pulmonary veins (PVs).3 To prevent complications of PV stenosis, this method was modified to electrical isolation of the PV by segmental isolation at the ostium.4, 5 Strategies evolved to include wide area encircling of the PV antrum using sophisticated three-dimensional mapping systems that could reconstruct atrial anatomy for guiding ablation and limiting fluoroscopy time.6, 7 In complex cases of persistent or permanent AF, additional ablation lines can be added, or complex fractionated electrograms can be targeted for ablation.8, 9, 10 The evolution in ablation strategies led to increasingly complex and lengthy procedures and the need for high-technology equipment. Intracardiac echocardiography, computed tomography/magnetic resonance imaging (MRI) integration, and robotic steering have been proposed as new tools for facilitating the procedure. However, the availability of imaging, mapping, and steering options has not necessarily led to better outcomes for patients, and a wide range of success rates is reported in the literature.11

Little progress has been made in the development of new ablation catheters. Traditional catheter ablation is performed in a single-tip, point-by-point ablation process. This technique requires a high degree of operator skill and procedures are lengthy, often more than 4 hours. In addition, creating reliable contiguous transmural lesions with a single-point catheter is difficult. Therefore, there is a need for specialized RF ablation catheters specifically designed for AF ablation. Alternative energy sources currently under investigation may offer advantages over conventional unipolar RF ablation. Here we describe a novel technique for isolation of the PVs by ablation using an over-the-wire multielectrode catheter delivering duty-cycled bipolar and unipolar RF energy at relatively low power.12, 13, 14, 15, 16

Section snippets

Patients and procedure

The study consisted of 98 consecutive patients with paroxysmal or persistent AF seen at the St. Antonius Hospital, Nieuwegein, The Netherlands, between April 2007 and June 2008. Patients were referred by outside cardiologists and were eligible for ablation if they had documented evidence of recurring symptomatic AF refractory to two or more antiarrhythmic drugs within the past 6 months. The study was approved by the St. Antonius Hospital review board, and all patients gave informed consent to

Results

The characteristics of the study group are given in Table 1. Among the 98 patients undergoing the ablation procedure, 23 were female. Mean patient age was 59 ± 9 years (range 34–76 years). Slight left atrial enlargement (40–45 mm) was seen in 18% of patients, and mild (less than grade 2) mitral insufficiency was seen in 12% of patients. The number of antiarrhythmic drugs used prior to ablation was 2 ± 1; only eight patients were taking amiodarone at inclusion into the study. In this patient

Discussion

This study reports the first clinical results of a new decapolar catheter that delivers bipolar/unipolar RF energy and can be used for both mapping and ablation of AF, with no need for three-dimensional imaging or remote navigation.

Conclusion

PV isolation by antrum ablation with a circular, multielectrode catheter using duty-cycled bipolar and unipolar RF energy appears to be feasible and safe, with promising efficacy at 6 months. The fluoroscopy and procedural times appear to be shorter than those associated with current AF ablation techniques, without the need for sophisticated mapping and/or steering modalities.

Acknowledgments

We thank Jay Kelley for manuscript preparation and review and Sadaf Soleymani for Figure 3.

References (32)

  • H. Oral et al.

    Circumferential pulmonary-vein ablation for chronic atrial fibrillation

    N Engl J Med

    (2006)
  • C. Pappone et al.

    Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation

    Circulation

    (2000)
  • H. Oral et al.

    Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation

    Circulation

    (2003)
  • A. Natale et al.

    Venice Chart International consensus document on atrial fibrillation ablation

    J Cardiovasc Electrophysiol

    (2007)
  • L. Dang et al.

    Multi-electrode catheters using low energy phased radiofrequency for ablation of chronic atrial fibrillation

    Europace

    (2008)
  • G.F. Michaud et al.

    Safety using novel multi-array catheters and phased radiofrequency energy in left atrial ablation for persistent atrial fibrillation

    Heart Rhythm

    (2008)
  • Cited by (0)

    Dr. Boersma is a stockholder with Ablation Frontiers Inc. Dr. Wijffels has received grant support for research from Ablation Frontiers, Inc. Dr. Oral is a stockholder and a consultant of Ablation Frontiers, Inc. Dr. Morady is a stockholder and a consultant of Ablation Frontiers, Inc.

    View full text